$0.33
-0.00 (-0.99%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where NXL is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 2 tracked-famous managers (CITADEL ADVISORS LLC, JANE STREET GROUP, LLC) · FINRA short interest 1.5 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe InsomniaNCT07659366Change in Insomnia Severity Index (ISI) Total Score at Week 4Randomized · Triple-masked · Treatment | Not applicable | Not yet recruiting | Device: Transcranial alternating current stimulator | Moderate to Severe Insomnia | 160 | 2027-07-01 | in 315 d | 2026-06-23 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19